Prodromal Depression and Subsequent Risk of Developing Parkinson’s Disease: A Systematic Review With meta-analysis

References

• Schrag A , HorsfallL, WaltersK, NoyceA, PetersenI. Prediagnostic presentations of Parkinson’s disease in primary care: a case-control study. Lancet Neurol., 14, 57–64 (2015).
   PubMed Web of Science ®Google Scholar
• Lieberman A . Depression in Parkinson’s disease – a review. Acta Neurol. Scand., 113, 1–8 (2006).
   PubMed Web of Science ®Google Scholar
• Hustad E , AaslyJO. Clinical and imaging markers of prodromal Parkinson’s disease. Front. Neurol., 11, 395 (2020).
   PubMed Web of Science ®Google Scholar
• Iranzo A . Parkinson disease and sleep: sleep–wake changes in the premotor stage of Parkinson disease; impaired olfaction and other prodromal features. Curr. Neurol. Neurosci. Reports, 13, 1–9 (2013).
   Web of Science ®Google Scholar
• Shen CC , TsaiSJ, PerngCL, KuoBIT, YangAC. Risk of Parkinson disease after depression: a nationwide population-based study. Neurology, 81, 1538–1544 (2013).
   PubMed Web of Science ®Google Scholar
• Schuurman A et al. Increased risk of Parkinson’s disease after depression: a retrospective cohort study. Neurology, 58, 1501–1504 (2002).
   PubMed Web of Science ®Google Scholar
• Jacob E , GattoN, ThompsonA, BordelonY, RitzB. Occurrence of depression and anxiety prior to Parkinson’s disease. Parkinsonism Relat. Disord., 16, 576–581 (2010).
   PubMed Web of Science ®Google Scholar
• Page MJ et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ, 372, (2021).
   Google Scholar
• Higgins JP , ThompsonSG. Quantifying heterogeneity in a meta-analysis. Stat. Med., 21, 1539–1558 (2002).
   PubMed Web of Science ®Google Scholar
• Freeman MF , TukeyJW. Transformations related to the angular and the square root. Annals Mathematical Statistics, 21, 607–611 (1950).
   Google Scholar
• Zeng X et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J. Evid. Based Med., 8, 2–10 (2015).
   PubMedGoogle Scholar
• Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol., 25, 603–605 (2010).
   PubMed Web of Science ®Google Scholar
• Fang F et al. Depression and the subsequent risk of Parkinson’s disease in the NIH-AARP Diet and Health Study. Mov. Disord., 25, 1157–1162 (2010).
   PubMed Web of Science ®Google Scholar
• Shiba M et al. Anxiety disorders and depressive disorders preceding Parkinson’s disease: a case-control study. Mov. Disord., 15, 669–677 (2000).
   PubMed Web of Science ®Google Scholar
• Plouvier AO et al. Prodromal symptoms and early detection of Parkinson’s disease in general practice: a nested case-control study. Fam. Pract., 31, 373–378 (2014).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Violante M et al. Premotor symptoms and the risk of Parkinson’s disease: a case-control study in Mexican population. Clin. Neurol. Neurosurg., 160, 46–49 (2017).
   PubMed Web of Science ®Google Scholar
• Becker C , BrobertG, JohanssonS, JickS, MeierC. Risk of incident depression in patients with Parkinson disease in the UK. Eur. J. Neurol., 18, 448–453 (2011).
   PubMed Web of Science ®Google Scholar
• Gaenslen A , SwidI, Liepelt-ScarfoneI, GodauJ, BergD. The patients’ perception of prodromal symptoms before the initial diagnosis of Parkinson’s disease. Mov. Disord., 26, 653–658 (2011).
   PubMed Web of Science ®Google Scholar
• Sanyal J et al. Environmental and familial risk factors of Parkinsons disease: case-control study. Can. J. Neurol. Sci., 37, 637–642 (2010).
   PubMed Web of Science ®Google Scholar
• Gustafsson H , NordströmA, NordströmP. Depression and subsequent risk of Parkinson disease: a nationwide cohort study. Neurology, 84, 2422–2429 (2015).
   PubMed Web of Science ®Google Scholar
• Szatmári S Jr , AjtayA, OberfrankF, DobiB, BereczkiD. The prevalence of psychiatric symptoms before the diagnosis of Parkinson’s disease in a nationwide cohort: a comparison to patients with cerebral infarction. PLoS ONE, 15, e0236728 (2020).
   PubMed Web of Science ®Google Scholar
• Nilsson F , KessingL, BolwigT. Increased risk of developing Parkinson’s disease for patients with major affective disorder: a register study. Acta Psychiatr. Scand., 104, 380–386 (2001).
   PubMed Web of Science ®Google Scholar
• Gu SC , ZhouJ, YuanCX, YeQ. Personalized prediction of depression in patients with newly diagnosed Parkinson’s disease: a prospective cohort study. J. Affect. Disord., 268, 118–126 (2020).
   PubMed Web of Science ®Google Scholar
• Pontone GM et al. The longitudinal impact of depression on disability in Parkinson disease. Int. J. Geriatr. Psychiatry, 31, 458–465 (2016).
   PubMed Web of Science ®Google Scholar
• Wang S , MaoS, XiangD, FangC. Association between depression and the subsequent risk of Parkinson’s disease: a meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry, 86, 186–192 (2018).
   PubMed Web of Science ®Google Scholar
• Postuma RB et al. Identifying prodromal Parkinson’s disease: pre-motor disorders in Parkinson’s disease. Mov. Disord., 27, 617–626 (2012).
   PubMed Web of Science ®Google Scholar
• Walter U et al. Potential impact of self-perceived prodromal symptoms on the early diagnosis of Parkinson’s disease. J. Neurol., 260, 3077–3085 (2013).
   PubMed Web of Science ®Google Scholar
• Pellicano C et al. Prodromal non-motor symptoms of Parkinson’s disease. Neuropsychiatr. Dis. Treat., 3, 145 (2007).
   PubMedGoogle Scholar
• Cui SS et al. Prevalence and risk factors for depression and anxiety in Chinese patients with Parkinson disease. BMC Geriatr., 17, 1–10 (2017).
   PubMed Web of Science ®Google Scholar
• Khedr EM , AbdelrahmanAA, ElserogyY, ZakiAF, GameaA. Depression and anxiety among patients with Parkinson’s disease: frequency, risk factors, and impact on quality of life. Egyp. J. Neuro., Psych. & Neurosurgery, 56, 1–9 (2020).
   Google Scholar
• Lerche S et al. Risk factors and prodromal markers and the development of Parkinson’s disease. J. Neurol., 261, 180–187 (2014).
   PubMed Web of Science ®Google Scholar
• Bora E , FornitoA, PantelisC, YücelM. Gray matter abnormalities in major depressive disorder: a meta-analysis of voxel based morphometry studies. J. Affect. Disord., 138, 9–18 (2012).
   PubMed Web of Science ®Google Scholar
• Benoit M , RobertPH. Imaging correlates of apathy and depression in Parkinson’s disease. J. Neurol. Sci., 310, 58–60 (2011).
   PubMed Web of Science ®Google Scholar
• Ak S , YağcıoğluAEA. Escitalopram-induced parkinsonism. Gen. Hosp. Psychiatry, 36, 126.e121–126.e122 (2014).
   Web of Science ®Google Scholar